EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches

Yuichi Kumaki, Goshi Oda, Sadakatsu Ikeda

Cancers · 14.09.2023 · 15 (18) · 4552

DOI: 10.3390/cancers15184552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.09.2023. Verfasst von Yuichi Kumaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Specialized Surgery, Tokyo Medical and Dental University, Tokyo 113-8519, Japan. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The MET gene plays a vital role in cellular proliferation, earning it recognition as a principal oncogene. Therapies that target MET amplification have demonstrated promising results both in preclinical models and in specific clinical cases. A significant obstacle to these therapies is the ability to distinguish between focal amplification and polysomy, a task for which simple MET copy number measurement proves insufficient. To effectively differentiate between the two, it is crucial to utilize comparative measures, including in situ hybridization (ISH) with the centromere or next generation sequencing (NGS) with adjacent genes. Despite the promising potential of MET amplification treatment, the judicious selection of patients is paramount to maximize therapeutic efficacy. The effectiveness of MET inhibitors can fluctuate depending on the extent of MET amplification. Future research must seek to establish the ideal threshold value for MET amplification, identify the most efficacious combination therapies, and innovate new targeted treatments for patients exhibiting MET amplification.

Schlagwörter

Stichwörter der Autor:innen

MET amplificationMET inhibitoracquired resistanceaneuploidypolysomy

Autor:innen und Institutionen

  • Department of Specialized Surgery, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
  • Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
  • Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.

Zitieren

APA

Kumaki, Y., Oda, G., & Ikeda, S. (2023). Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches. Cancers, 15(18), 4552. https://doi.org/10.3390/cancers15184552

Vancouver

Kumaki Y, Oda G, Ikeda S. Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches. Cancers. 2023;15(18):4552. doi:10.3390/cancers15184552

BibTeX
@article{Kumaki2023,
  author = {Kumaki, Yuichi and Oda, Goshi and Ikeda, Sadakatsu},
  title = {Targeting MET Amplification: Opportunities and Obstacles in Therapeutic Approaches},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {18},
  pages = {4552},
  doi = {10.3390/cancers15184552}
}
Kostenlos starten →